Ads
related to: drugs that replace warfarin- Full Prescribing Info
View Prescribing Information For
XARELTO® Tablets
- XARELTO® Cost Info
How Much Will I Need to Pay?
View XARELTO® Savings Information
- XARELTO® Dosing
View Dosing Guide & Prescribing
Info Across 11 Indications
- Save on XARELTO®
Janssen CarePath Savings Program
2024 Program Requirements Apply
- XARELTO® FAQs
Find Answers To Frequently Asked
Questions About XARELTO®
- XARELTO® Safety Profile
XARELTO® Has Been Studied Across A
Wide Range Of Patient Types
- Full Prescribing Info
wolterskluwer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Direct factor Xa inhibitors can be considered as an alternative to warfarin, particularly if a person is on several other medications that interact with warfarin, or if attending medical appointments and laboratory monitoring becomes difficult. [8]
Dabigatran is an oral direct thrombin inhibitor. Dabigatran (Pradaxa) was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial. [9]
Ximelagatran (Exanta or Exarta, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin [1] that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy.
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [8]
Due to a limitation identified in long-term stability of the extended-release AZD0837 drug product, a follow-up study from ASSURE on stroke prevention in patients with non-valvular atrial fibrillation, was prematurely closed in 2010 after 2 years. There was also a numerically higher mortality against warfarin.
Warfarin treatment requires blood monitoring and dose adjustments regularly due to its narrow therapeutic window. If supervision isn't adequate warfarin poses a threat in causing, all too frequent, haemorrhagic events and multiple interactions with food and other drugs.
Ad
related to: drugs that replace warfarin